@nat_kady is presenting the results of her excellent analysis on the impact of gabapentinoid reclassification on prescribing rates in the UK. Find out more at poster #187 today at the World Congress on Pain.
#WC2024#IASP2024@DundeeCPRG@UoDMedicine@Painstorm_APDP – at Amsterdam, The Netherlands